Turmeric and joints: the evidence
Osteoarthritis affects over 500 million people worldwide. Curcumin, the active compound in turmeric, shows impressive results in clinical trials — comparable to conventional painkillers but with a better safety profile.
Curcumin vs ibuprofen: the RCT
Kuptniratsaikul et al. (2014), published in Clinical Interventions in Aging, compared curcumin (1500mg/day) with ibuprofen (1200mg/day) in 367 patients with knee osteoarthritis:
- Comparable efficacy for pain and joint function
- Fewer gastrointestinal side effects in the curcumin group
- Comparable patient satisfaction
NF-κB: the inflammatory mechanism
| Agent | Target | Mechanism | Side effects |
|---|---|---|---|
| Ibuprofen | COX-1/COX-2 | Enzyme inhibition | Stomach ulcers, kidney damage, CV risk |
| Curcumin | IKK-β | Kinase inhibition | Minimal |
| Gingerol | IκBα | Stabilization | Minimal |
| Curcumin + Gingerol | Double NF-κB | Synergistic | Minimal |
The bioavailability problem
Curcumin is rapidly degraded by the enzyme UDP-glucuronosyltransferase. Without piperine, less than 1% reaches the bloodstream. With piperine: 2000% improvement (Shoba et al., 1998).
The sugar problem
Sugar activates NF-κB (Mauro et al., 2011) — the same inflammatory pathway that curcumin attempts to inhibit. A product with 34g sugar/100ml activates inflammation while claiming to fight it.
INTI — organic ginger + turmeric + black pepper, 1.19g sugar/100ml. Joint protection without the sugar paradox.